OVERVIEW

Evolving Therapeutic Options for Moderate-to-Severe Asthma: A Comprehensive 3-Dimensional Study is organized by Med Learning Group and will be held from Dec 07, 2018 - Dec 07, 2019.

Target Audience:
This CME initiative is designed to meet the educational needs of pulmonologists, allergists, immunologists and primary care physicians who are involved in the healthcare of patients with severe asthma.

Description:
This case-based enduring activity will cover the treatment and management of patients with chronic or severe asthma.

Learning Objectives:
Upon completion of the CME activity, learners should be better able to:
• Assess the causes of underlying inflammation in asthma, and resulting targets of therapy
• Evaluate the level of asthma control, disease severity, and exacerbation risk to better drive appropriate treatment
• Review currently-available and novel targeted therapies and their effect on treatment strategies for patients with moderate-to-severe asthma.

Additional details will be posted as soon as they are available.